Hydroxy-methyl-glutaryl CoA reductase inhibitors or statins are the most effective medications for reducing elevated concentrations of low-density lipoprotein (LDL) cho-lesterol and produce remarkable reductions in cardiovascular events.1 Statins can produce life-threatening rhabdomyolysis, but this is rare.2 Statins are more frequently associated with mild muscle complaints, including myalgia, cramps, and weakness, which may compromise medication compliance and quality of life. The reported incidence of myalgia during statin therapy ranges from 1 % in controlled studies3 to 25% in clinical reports.4 Muscle weakness has also been reported with statin therapy, but muscle performance and exercise per-formance have not been carefully studied.
BACKGROUND: HMG-CoA reductase inhibitors (statins) are a common and effective pharmacological means ...
vol. 3 • no. 4 It would behoove health care professionals to counsel dyslipidemic patients about the...
Statins, or 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors, are among the most...
Objective: To review the epidemiology, clinical features, proposed mechanisms, risk factors, and man...
Introduction: Statins remain among the most frequently prescribed drugs and constitute a cornerstone...
Source of support: Departmental sources Background: Statin use is frequently associated with muscle-...
Statins are considered to be safe, well tolerated and the most efficient drugs for the treatment of ...
Hyperlipidemia is a major risk factor for cardiovascular morbidity and mortality. Statins are the fi...
In the United States there are more than 40 million Americans that treat or prevent hyperlipidemia a...
Khalesi Taharoom, SS ORCiD: 0000-0002-8208-2518Addressing the factors which lead to the development ...
S tatins are considered very effectivein reducing cardiovascular morbid-ity and mortality in high-ri...
Statin-associated muscle symptoms (SAMSs) vary considerably in frequency and severity, with a spectr...
J. Koltveit & L. F. Stegall Hamline University, St. Paul, MN Cardiovascular Disease (CVD) is the lea...
are well-established agents for the treat-ment of dyslipidemia and reduction of cardiovascular event...
Hyperlipidaemia is a major risk factor for cardiovascular morbidity and mortality. 3-hydroxy-3-methy...
BACKGROUND: HMG-CoA reductase inhibitors (statins) are a common and effective pharmacological means ...
vol. 3 • no. 4 It would behoove health care professionals to counsel dyslipidemic patients about the...
Statins, or 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors, are among the most...
Objective: To review the epidemiology, clinical features, proposed mechanisms, risk factors, and man...
Introduction: Statins remain among the most frequently prescribed drugs and constitute a cornerstone...
Source of support: Departmental sources Background: Statin use is frequently associated with muscle-...
Statins are considered to be safe, well tolerated and the most efficient drugs for the treatment of ...
Hyperlipidemia is a major risk factor for cardiovascular morbidity and mortality. Statins are the fi...
In the United States there are more than 40 million Americans that treat or prevent hyperlipidemia a...
Khalesi Taharoom, SS ORCiD: 0000-0002-8208-2518Addressing the factors which lead to the development ...
S tatins are considered very effectivein reducing cardiovascular morbid-ity and mortality in high-ri...
Statin-associated muscle symptoms (SAMSs) vary considerably in frequency and severity, with a spectr...
J. Koltveit & L. F. Stegall Hamline University, St. Paul, MN Cardiovascular Disease (CVD) is the lea...
are well-established agents for the treat-ment of dyslipidemia and reduction of cardiovascular event...
Hyperlipidaemia is a major risk factor for cardiovascular morbidity and mortality. 3-hydroxy-3-methy...
BACKGROUND: HMG-CoA reductase inhibitors (statins) are a common and effective pharmacological means ...
vol. 3 • no. 4 It would behoove health care professionals to counsel dyslipidemic patients about the...
Statins, or 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors, are among the most...